Digital Therapeutics Market: Innovations in Patient Care

The global digital therapeutics market size is expected to reach USD 32.52 billion by 2030, exhibiting a CAGR of 27.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary driver for expanding the market growth is the increased use of smartphones. The affordability of digital health technologies for healthcare providers & patients, rising demand for integrated healthcare systems, and care focusing on the patient are key factors fueling the market's growth. Furthermore, the growing globalization and shifts in lifestyle habits, such as higher rates of tobacco use, inadequate nutrition, insufficient physical activity, and rising alcohol consumption, increase the likelihood of chronic disease development.

Gather more insights about the market drivers, restrains and growth of the Global Digital Therapeutics Market

The market’s expansion is significantly influenced by the increasing adoption of digital therapeutics and the supportive initiatives by leading regulatory agencies such as the FDA. For instance, the U.S. FDA provided guidelines in April 2020 to enhance the reach of digital therapeutic devices for people suffering from psychiatric disorders. Furthermore, according to Kepios data, there's a 7.6% annual growth rate in the global internet user base, translating to around 900,000 new internet users daily. While developed and developing nations boast high smartphone and internet usage levels, areas such as Africa and South Asia need to catch up due to their economic limitations.

Increasing prevalence of chronic diseases is also driving the growth of the market. As per the CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have two or more chronic diseases. For instance, in February 2022, Teladoc Health, Inc. launched Chronic Care Complete, a chronic condition management solution to improve healthcare outcomes. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer’s have been identified as the leading causes of death and disability in the country.

Digital Therapeutics Market Report Highlights

• Based on application, diabetes held a market share of 29.36% in 2023, owing to rapid technological advancements by market players in the segment. The segment is also expected to witness the fastest growth over the forecast period

• The patients segment held the largest market share of 34.08% in 2023, owing to the growing number of patients suffering from chronic conditions. Digital therapeutics can also help improve access to care for people, especially those from rural and remote areas

• North America dominated the global market in 2023 owing to the high demand for digital therapeutics in the region. These regional marketplaces are expected to show similar trends throughout the forecast period due to rising healthcare awareness coupled with increased use of digital health products over the forecast period

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global healthcare application lifecycle management solutions market size was estimated at USD 630.8 million in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to 2030.

• The India clinical trials market is valued at USD 1.42 billion in 2024 and is expected to grow at a CAGR of 8.0% from 2025 to 2030, driven by the expanding pharmaceutical and biotechnology sectors.

Segments Covered in the Report

Grand View Research has segmented the global digital therapeutics market based on application, end user, and region:

Digital Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes

• Obesity

• CVD

• Respiratory Diseases

• Smoking Cessation

• CNS Diseases

• Others

Digital Therapeutics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Patients

• Providers

• Payers

• Employers

• Others

Digital Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

Order a free sample PDF of the Digital Therapeutics Market Intelligence Study, published by Grand View Research.